CN108686049A - 一种用于疏通乳腺的中药膏及其制备方法 - Google Patents
一种用于疏通乳腺的中药膏及其制备方法 Download PDFInfo
- Publication number
- CN108686049A CN108686049A CN201810701005.5A CN201810701005A CN108686049A CN 108686049 A CN108686049 A CN 108686049A CN 201810701005 A CN201810701005 A CN 201810701005A CN 108686049 A CN108686049 A CN 108686049A
- Authority
- CN
- China
- Prior art keywords
- parts
- component
- traditional chinese
- root
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 36
- 210000005075 mammary gland Anatomy 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 241000218176 Corydalis Species 0.000 claims abstract description 38
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 22
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 22
- 244000290970 Tetrapanax papyrifer Species 0.000 claims abstract description 21
- 241000208671 Campanulaceae Species 0.000 claims abstract description 20
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 20
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 20
- 241000612118 Samolus valerandi Species 0.000 claims abstract description 20
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 19
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 19
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 19
- 239000004863 Frankincense Substances 0.000 claims abstract description 19
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 19
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 19
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 19
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 19
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 19
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 19
- 235000003956 Luffa Nutrition 0.000 claims abstract description 18
- 241000718543 Ormosia krugii Species 0.000 claims abstract description 18
- 244000226566 Psoralea corylifolia Species 0.000 claims abstract description 18
- 241001165494 Rhodiola Species 0.000 claims abstract description 18
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract description 18
- 241000123589 Dipsacus Species 0.000 claims abstract description 17
- 206010047700 Vomiting Diseases 0.000 claims abstract description 17
- 230000008673 vomiting Effects 0.000 claims abstract description 17
- 241001233914 Chelidonium majus Species 0.000 claims abstract description 15
- 210000000582 semen Anatomy 0.000 claims abstract description 10
- 244000050983 Luffa operculata Species 0.000 claims abstract 4
- 244000192528 Chrysanthemum parthenium Species 0.000 claims abstract 3
- 239000000203 mixture Substances 0.000 claims description 23
- 241000245665 Taraxacum Species 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 20
- 238000004659 sterilization and disinfection Methods 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 16
- 239000003390 Chinese drug Substances 0.000 claims description 15
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 claims description 14
- 229940070384 ventolin Drugs 0.000 claims description 14
- 210000000481 breast Anatomy 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 8
- 238000011049 filling Methods 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 239000000835 fiber Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000011159 matrix material Substances 0.000 claims description 5
- 238000003801 milling Methods 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 230000000249 desinfective effect Effects 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 2
- 244000241257 Cucumis melo Species 0.000 claims 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims 1
- 238000002386 leaching Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 27
- 208000002193 Pain Diseases 0.000 abstract description 14
- 230000036407 pain Effects 0.000 abstract description 14
- 230000001737 promoting effect Effects 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 5
- 230000004087 circulation Effects 0.000 abstract description 5
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 241000207925 Leonurus Species 0.000 description 16
- 241000219138 Luffa Species 0.000 description 14
- 235000014571 nuts Nutrition 0.000 description 12
- 239000000126 substance Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 208000004396 mastitis Diseases 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 3
- 235000015363 Amaranthus cruentus Nutrition 0.000 description 3
- 240000003147 Amaranthus hypochondriacus Species 0.000 description 3
- 235000011746 Amaranthus hypochondriacus Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 3
- 230000002146 bilateral effect Effects 0.000 description 3
- -1 corynoline Natural products 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- HEVGGTGPGPKZHF-UHFFFAOYSA-N 1-(1,2-dimethyl-3-methylidenecyclopentyl)-4-methylbenzene Chemical compound CC1C(=C)CCC1(C)C1=CC=C(C)C=C1 HEVGGTGPGPKZHF-UHFFFAOYSA-N 0.000 description 2
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 2
- CRZQGDNQQAALAY-UHFFFAOYSA-N Methyl benzeneacetate Chemical compound COC(=O)CC1=CC=CC=C1 CRZQGDNQQAALAY-UHFFFAOYSA-N 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 244000178320 Vaccaria pyramidata Species 0.000 description 2
- 235000010587 Vaccaria pyramidata Nutrition 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- OPMNROCQHKJDAQ-FKSUSPILSA-N loline Chemical compound C1C[C@@H]2O[C@H]3[C@H](NC)[C@@H]2N1C3 OPMNROCQHKJDAQ-FKSUSPILSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 229940043263 traditional drug Drugs 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QQUHMASGPODSIW-UHFFFAOYSA-N Albiflorin Natural products C=1C=CC=CC=1C(=O)OCC12C(=O)OC3(C)CC(O)C1CC32OC1OC(CO)C(O)C(O)C1O QQUHMASGPODSIW-UHFFFAOYSA-N 0.000 description 1
- UIERETOOQGIECD-UHFFFAOYSA-N Angelic acid Natural products CC=C(C)C(O)=O UIERETOOQGIECD-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010006256 Breast hyperplasia Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- IQUGPRHKZNCHGC-UHFFFAOYSA-N Corynoline Natural products C1=C2C3N(C)CC4=C(OCO5)C5=CC=C4C3(C)C(O)CC2=CC2=C1OCO2 IQUGPRHKZNCHGC-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000825107 Hierochloe Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- RMFGNMMNUZWCRZ-UHFFFAOYSA-N Humulone Natural products CC(C)CC(=O)C1=C(O)C(O)(CC=C(C)C)C(O)=C(CC=C(C)C)C1=O RMFGNMMNUZWCRZ-UHFFFAOYSA-N 0.000 description 1
- GYIKGLVKALOGDP-DSBKMWIDSA-N Isovitexin 4'-O-glucoside 2''-O-arabinoside Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1c1c(O)c2C(=O)C=C(c3ccc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)cc3)Oc2cc1O)[C@@H]1[C@H](O)[C@H](O)[C@H](O)CO1 GYIKGLVKALOGDP-DSBKMWIDSA-N 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- 240000007890 Leonurus cardiaca Species 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 244000302544 Luffa aegyptiaca Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- CZCIKBSVHDNIDH-NSHDSACASA-N N(alpha)-methyl-L-tryptophan Chemical compound C1=CC=C2C(C[C@H]([NH2+]C)C([O-])=O)=CNC2=C1 CZCIKBSVHDNIDH-NSHDSACASA-N 0.000 description 1
- CZCIKBSVHDNIDH-UHFFFAOYSA-N Nalpha-methyl-DL-tryptophan Natural products C1=CC=C2C(CC(NC)C(O)=O)=CNC2=C1 CZCIKBSVHDNIDH-UHFFFAOYSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- VZRKWGPIZJDNHC-LUNVCWBOSA-N Polygalic acid Polymers CC1(C)CC[C@@]2(CCC3=C(CC[C@@H]4[C@@]5(C)C[C@H](O)[C@H](O)[C@](C)([C@@H]5CC[C@@]34C)C(O)=O)[C@@H]2C1)C(O)=O VZRKWGPIZJDNHC-LUNVCWBOSA-N 0.000 description 1
- VZRKWGPIZJDNHC-UHFFFAOYSA-N Polygalic acid Natural products CC1(C)CCC2(CCC3=C(CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(O)=O)C2C1)C(O)=O VZRKWGPIZJDNHC-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001248672 Rhinacanthus Species 0.000 description 1
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 244000107975 Strychnos nux-vomica Species 0.000 description 1
- GYIKGLVKALOGDP-HLEFUGOVSA-N Vaccarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C=2OC3=CC(O)=C([C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@H]4[C@@H]([C@@H](O)[C@@H](O)CO4)O)C(O)=C3C(=O)C=2)C=C1 GYIKGLVKALOGDP-HLEFUGOVSA-N 0.000 description 1
- GYIKGLVKALOGDP-UHFFFAOYSA-N Vaccarin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=C(C4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)CO4)O)C(O)=C3C(=O)C=2)C=C1 GYIKGLVKALOGDP-UHFFFAOYSA-N 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- QQUHMASGPODSIW-ICECTASOSA-N albiflorin Chemical compound O([C@@]12C[C@H]3[C@H](O)C[C@@]1(OC(=O)[C@]32COC(=O)C=1C=CC=CC=1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QQUHMASGPODSIW-ICECTASOSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- UIERETOOQGIECD-ARJAWSKDSA-N angelic acid Chemical compound C\C=C(\C)C(O)=O UIERETOOQGIECD-ARJAWSKDSA-N 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- IQUGPRHKZNCHGC-TYPHKJRUSA-N corynoline Chemical compound C1=C2[C@H]3N(C)CC4=C(OCO5)C5=CC=C4[C@@]3(C)[C@@H](O)CC2=CC2=C1OCO2 IQUGPRHKZNCHGC-TYPHKJRUSA-N 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- UKIOTQZYKUPESG-UHFFFAOYSA-N dl-Tetrahydrocoptisine Natural products C1=C2C(C)C3C4=CC(OCO5)=C5C=C4CCN3CC2=C2OCOC2=C1 UKIOTQZYKUPESG-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- OPMNROCQHKJDAQ-UHFFFAOYSA-N festucine Natural products C1CC2OC3C(NC)C2N1C3 OPMNROCQHKJDAQ-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- VMSLCPKYRPDHLN-NRFANRHFSA-N humulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)[C@@](O)(CC=C(C)C)C1=O VMSLCPKYRPDHLN-NRFANRHFSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000009835 oxypaeoniflora Substances 0.000 description 1
- FCHVXNVDFYXLIL-QYDSDWLYSA-N oxypaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@@]1(C[C@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=C(O)C=C1 FCHVXNVDFYXLIL-QYDSDWLYSA-N 0.000 description 1
- RLXWQODPAWIVOI-UHFFFAOYSA-N oxypaeoniflorin Natural products OCC1OC(OC23CC4C5(O)CC2OC(O5)C34COC(=O)c6ccc(O)cc6)C(O)C(O)C1O RLXWQODPAWIVOI-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- GWBIYORWNUYYMZ-UHFFFAOYSA-N platycodin D Natural products CC1OC(OC2C(O)C(O)COC2OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CC(O)C(OC8CC(CO)C(O)C(O)C8O)C(CO)(CO)C7CCC6(C)C5(C)CC4O)C(O)C(O)C1OC9OCC(O)C(OC%10OCC(O)(CO)C%10O)C9O GWBIYORWNUYYMZ-UHFFFAOYSA-N 0.000 description 1
- CYBWUNOAQPMRBA-NDTOZIJESA-N platycodin D Chemical compound O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2C1(CO)CO)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CYBWUNOAQPMRBA-NDTOZIJESA-N 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- XXRYFVCIMARHRS-UHFFFAOYSA-N propan-2-yl n-dimethoxyphosphorylcarbamate Chemical compound COP(=O)(OC)NC(=O)OC(C)C XXRYFVCIMARHRS-UHFFFAOYSA-N 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- UXYJCYXWJGAKQY-UHFFFAOYSA-N stylopine Chemical compound C1C2=C3OCOC3=CC=C2CC2N1CCC1=C2C=C(OCO2)C2=C1 UXYJCYXWJGAKQY-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pregnancy & Childbirth (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种用于疏通乳腺的中药膏及其制备方法,按重量份计,包括中药A、B组分:A组分包括野菊花20‑40份、蒲公英30‑60份、地丁草20‑40份、炒王不留行5‑15份、通草5‑12份、丝瓜络15‑30份、桔梗10‑30份、川芎10‑30份、当归10‑30份、赤芍10‑30份、益母草15‑40份、炙甘草5‑15份、乳香3‑5份;B组分包括鸡骨草10‑30份、泽兰20‑30份、芒硝3‑5份、延胡索3‑5份、马钱子0.5‑2份、水红花子1‑5份、鸡血藤10‑15份、徐长卿1‑5份、红景天8‑10份、补骨脂0.5‑3份、续断10‑15份。本发明中药膏具有消炎活血,行气止痛的作用,疏通乳腺效果好。
Description
技术领域
本发明涉及一种用于疏通乳腺的中药膏及其制备方法,属于中药技术领域。
背景技术
现今女性越来越注意女性方面的保健,特别是孕期后的妇女往往存在乳腺疏通不畅的问题,胶囊等内服品等有增乳疏通功效的产品越来越多,但是这些产品多是直接进入身体,由此会产生一定的副作用和依赖性甚至会造成伤害。
目前,有中国专利“一种具有乳腺疏通功效的药油”(申请号为201711247718.0),将连翘、红花、当归、香附、柴胡、白芍、丹参、乳香、三七、川穹这些原料混合漂洗烘干粉碎过筛然后放入超流体萃取机的萃取器中,调整压力到萃取压力值时,温度升到萃取温度值时经过一定萃取时间后,再将压力调整至分离压力值,温度下降到分离温度值,全循环流程操作完毕从放油阀门将原料组分的萃取液提出,制得药油,该发明提取出有机原料中调理乳腺的成分并涂抹人体外表缓慢调理女性乳腺功能。上述药油的制备过程复杂,设备成本高。
另有中国专利“一种疏通乳腺敷膏”(申请号为201610294317.X),包括以下比例组份:核桃20~24份、龟板12~15份、猫爪草9~13份、枸杞子8~12份、大豆异黄酮10~14份、丙二醇13~16份、丁二醇7~9份、棕榈酸乙基己酯4~6份、聚二甲基硅氧烷2~5份、氢化聚葵烯2~5份、牛油果树果脂1~3份、PEG-100硬脂酸酯1~2份、矿油8~10份、白鹤灵芝提取物3~5份、十三烷醇聚醚-6 1~3份、聚丙烯酸钠0.1~0.3份、水解燕麦蛋白1~3份和白芍1~2份。该疏通乳腺敷膏中含有多种化学成分,长时间使用后,会在人体产生药物沉积残留,影响人体健康。
发明内容
针对上述现有技术存在的问题,本发明提供一种用于疏通乳腺的中药膏,具有消炎活血,行气止痛的作用,疏通乳腺效果好。
为了实现上述目的,本发明采用的一种用于疏通乳腺的中药膏,按重量份计,包括中药A组分和B组分:
所述A组分包括野菊花20-40份、蒲公英30-60份、地丁草20-40份、炒王不留行5-15份、通草5-12份、丝瓜络15-30份、桔梗10-30份、川芎10-30份、当归10-30份、赤芍10-30份、益母草15-40份、炙甘草5-15份、乳香3-5份;
所述B组分包括鸡骨草10-30份、泽兰20-30份、芒硝3-5份、延胡索3-5份、马钱子0.5-2份、水红花子1-5份、鸡血藤10-15份、徐长卿1-5份、红景天8-10份、补骨脂0.5-3份、续断10-15份。
作为改进,该用于疏通乳腺的中药膏,按重量份计,包括中药A组分和B组分:
所述A组分包括野菊花25-35份、蒲公英30-50份、地丁草20-35份、炒王不留行10-15份、通草5-10份、丝瓜络15-25份、桔梗15-25份、川芎15-25份、当归15-25份、赤芍15-25份、益母草15-30份、炙甘草10-15份、乳香4-5份;
所述B组分包括鸡骨草15-25份、泽兰20-25份、芒硝3.5-5份、延胡索3-4.5份、马钱子1-2份、水红花子1-3份、鸡血藤10-13份、徐长卿2.5-5份、红景天8-9份、补骨脂1.5-3份、续断11-14份。
作为改进,该用于疏通乳腺的中药膏,按重量份计,包括中药A组分和B组分:
所述A组分包括野菊花30份、蒲公英45份、地丁草25份、炒王不留行15份、通草8.5份、丝瓜络18.5份、桔梗20份、川芎20.5份、当归20份、赤芍18.5份、益母草20份、炙甘草14.5份、乳香4.5份;
所述B组分包括鸡骨草20份、泽兰22份、芒硝4.5份、延胡索4.5份、马钱子1份、水红花子1.8份、鸡血藤11.5份、徐长卿3.5份、红景天8份、补骨脂2.5份、续断12份。
另外,本发明还提供了一种用于疏通乳腺的中药膏的制备方法,包括以下步骤:
步骤一、准确称量需要的各中药组分,分别洗净后晾干备用;
步骤二、将A组分中的野菊花、蒲公英、地丁草、炒王不留行、通草、丝瓜络、桔梗、川芎、当归、赤芍、益母草、炙甘草、乳香筛检,消毒灭菌后将各组分打成100目细粉,过筛去除其中纤维,留粉末备用;
步骤三、将B组分中的鸡骨草、泽兰、芒硝、延胡索、马钱子、水红花子、鸡血藤、徐长卿、红景天、补骨脂、续断,混合磨粉,然后加入3-5倍量的去离子水,混合煎煮60-80min,然后过滤取煎煮液,继续文火加热搅拌,熬制浸膏备用;
步骤四、将步骤二中得到的粉末与步骤三得到的浸膏,于1200-1500rpm的搅拌速度下,搅拌2-5h,得到中药混合物,然后以医用凡士林为基质,按照中药混合物与医用凡士林的重量比为1:3,将中药混合物加至医用凡士林中,继续按照1200-1500rpm的搅拌速度,搅拌2-5h,再次杀菌处理,灌装,密封。
作为改进,所述的杀菌采用无菌净化及紫外线消毒,消毒温度为65-85℃,消毒时间为0.2-0.5h。
与现有技术相比,本发明的有益效果是:
1)本发明的中药组分中,野菊花、蒲公英、地丁草清热消炎;王不留行、通草、丝瓜络疏通乳腺管;川芎、当归、赤芍、益母草活血散结,防止乳汁淤积;桔梗宣肺抗炎;炙甘草调合诸药。
本发明以消炎通络为组方依据。中药蒲公英为君药,辅以其他清热消炎,疏通乳腺的中药野菊花、地丁草、王不留行(炒)、通草、丝瓜络、桔梗、川芎、当归、赤芍、益母草、炙甘草等。中药蒲公英含蒲公英甾醇、胆碱、菊糖和果胶等化学成分,对金黄色葡萄球菌有显著抑制作用,蒲公英具有清热解毒,消肿散结的功效,临床上对乳痈即乳腺炎有明显疗效。野菊花含菊醇、菊酮、α-蒎烯、樟脑、龙脑、樟烯等化学成分,野菊花具有清热解毒的功效,对金黄色葡萄球菌、白喉杆菌有抗菌作用,野菊花还有解热、增强巨噬细胞吞噬功能等作用。地丁草含消旋及右旋的紫堇醇灵碱、乙酰紫堇灵碱、四氢黄连碱、原阿片碱等生物碱;对链球菌、大肠杆菌、葡萄球菌等有抑菌作用,中医认为地丁草具有清热毒,消痈肿的功效。王不留行(炒)含王不留行黄酮苷、三萜皂苷等化学成分,具有活血通经、下乳消肿的功能,用于经闭,痛经,乳汁不下,乳痈肿痛,淋证涩痛(《中华人民共和国药典》(2010年版))。通草含多种通脱木苷、醇以及多聚戊糖,具有清热利尿,通气下乳的功效。丝瓜络主要含齐墩果酸,为广谱抗菌药,对金黄色葡萄球菌有抑制作用,同时具有祛风、通络、活血、下乳,用于胸胁胀痛,乳汁不通,乳痈肿痛。桔梗含多种皂苷其中最主要的是远志皂苷、桔梗皂苷D,具有镇静及抗炎作用。川芎含川芎嗪、黑麦草碱、川芎内酯、藁本内酯、阿魏酸、苯乙酸甲酯等化学成分,能抑制血栓形成及血小板的凝聚,具有活血行气的功效。当归含藁本内酯、阿魏酸、樟脑酸、癸二酸、月桂烯、当归酸等多种化学成分,能抑制血小板聚集,抗血栓形成,有抗贫血作用,具有活血补血的功效。赤芍主要含有单萜类化合物,如芍药苷、芍药内酯苷、氧化芍药苷等,具有解热抗炎的作用。益母草含益母草碱、水苏碱、前西班牙夏罗草酮、益母草二萜、苯甲酸、油酸、甾醇、芸香苷和多量氯化钾等,益母草有抑制血小板聚集作用,抑制凝血和血栓形成。炙甘草甘草苷、甘草酸等有效化学成分,具有抗炎、抗菌、解毒的作用。乳香活血止痛、消肿生肌。
2)本发明的中药组分中,鸡骨草全草含相思子碱,胆碱,甾醇化合物、黄酮类、等化学成分,具有清热、散瘀止痛的功效;泽兰含挥发油黄酮甙、皂甙、酚类等化学成分,具有活血化瘀、消肿的功效;芒硝含有水硫酸钠化学成分,外用乳房对急性乳腺炎有良好的治疗效果;延胡索活血、理气、止痛;马钱子祛风定痛、舒筋活络、散血热、消肿毒;水红花子消瘀破积、健脾利湿;鸡血藤补血行血、通经络、强筋骨;徐长卿祛风化湿、行气通络;红景天益气活血、通脉平喘,补骨脂温肾助阳、纳气、止泻,续断补肝肾、强筋骨、续折伤。本发明的中药膏针对性强,标本兼治,治愈率高,疗程短,疗效显著,愈后不复发,而且安全可靠,无毒副作用,治疗费用低,禁忌较少。
3)本发明采用的中药原料来源广,成本低,加工方便。另外,采用的中药组分除了本身具有的药性外,还能起到药引的效果,如徐长卿除了本身具有的祛风化湿、行气通络的效果,同时还能起到引药上行,使其他组分药效直达颈项以上,实现“理气”的效果,另外,如乳香活血止痛、消肿生肌,起到引药直达体表,实现“止痛”的效果。本发明中多组分都具有类似的情况,都可起到药引的效果。
4)本发明采用中药粉末与中药浸膏预混合,能使各中药组分充分混匀,相互协同起效,药效安全稳固。使用方便,可直接涂抹施药。
具体实施方式
为使本发明的目的、技术方案和优点更加清楚明了,下面对本发明进行进一步详细说明。但是应该理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限制本发明的范围。
除非另有定义,本文所使用的所有的技术术语和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同,本文中在本发明的说明书中所使用的术语只是为了描述具体的实施例的目的,不是旨在于限制本发明。
实施例1
一种用于疏通乳腺的中药膏,按重量份计,包括中药A组分和B组分:
所述A组分包括野菊花20份、蒲公英30份、地丁草20份、炒王不留行5份、通草5份、丝瓜络15份、桔梗10份、川芎10份、当归10份、赤芍10份、益母草15份、炙甘草5份、乳香3份;
所述B组分包括鸡骨草10份、泽兰20份、芒硝3份、延胡索3份、马钱子0.5份、水红花子1份、鸡血藤10份、徐长卿1份、红景天8份、补骨脂0.5份、续断10份。
上述用于疏通乳腺的中药膏的制备方法,包括以下步骤:
步骤一、准确称量需要的各中药组分,分别洗净后晾干备用;
步骤二、将A组分中的野菊花、蒲公英、地丁草、炒王不留行、通草、丝瓜络、桔梗、川芎、当归、赤芍、益母草、炙甘草、乳香筛检,消毒灭菌后将各组分打成100目细粉,过筛去除其中纤维,留粉末备用;
步骤三、将B组分中的鸡骨草、泽兰、芒硝、延胡索、马钱子、水红花子、鸡血藤、徐长卿、红景天、补骨脂、续断,混合磨粉,然后加入3倍量的去离子水,混合煎煮60min,然后过滤取煎煮液,继续文火加热搅拌,熬制浸膏备用;
步骤四、将步骤二中得到的粉末与步骤三得到的浸膏,于1200rpm的搅拌速度下,搅拌2h,得到中药混合物,然后以医用凡士林为基质,按照中药混合物与医用凡士林的重量比为1:3,将中药混合物加至医用凡士林中,继续按照1200rpm的搅拌速度,搅拌2h,然后采用无菌净化及紫外线消毒,消毒温度为65℃,消毒时间为0.2h,灌装,密封。
实施例2
一种用于疏通乳腺的中药膏,按重量份计,包括中药A组分和B组分:
所述A组分包括野菊花40份、蒲公英60份、地丁草40份、炒王不留行15份、通草12份、丝瓜络30份、桔梗30份、川芎30份、当归30份、赤芍30份、益母草40份、炙甘草15份、乳香5份;
所述B组分包括鸡骨草30份、泽兰30份、芒硝5份、延胡索5份、马钱子2份、水红花子5份、鸡血藤15份、徐长卿5份、红景天10份、补骨脂3份、续断15份。
上述用于疏通乳腺的中药膏的制备方法,包括以下步骤:
步骤一、准确称量需要的各中药组分,分别洗净后晾干备用;
步骤二、将A组分中的野菊花、蒲公英、地丁草、炒王不留行、通草、丝瓜络、桔梗、川芎、当归、赤芍、益母草、炙甘草、乳香筛检,消毒灭菌后将各组分打成100目细粉,过筛去除其中纤维,留粉末备用;
步骤三、将B组分中的鸡骨草、泽兰、芒硝、延胡索、马钱子、水红花子、鸡血藤、徐长卿、红景天、补骨脂、续断,混合磨粉,然后加入5倍量的去离子水,混合煎煮80min,然后过滤取煎煮液,继续文火加热搅拌,熬制浸膏备用;
步骤四、将步骤二中得到的粉末与步骤三得到的浸膏,于1500rpm的搅拌速度下,搅拌5h,得到中药混合物,然后以医用凡士林为基质,按照中药混合物与医用凡士林的重量比为1:3,将中药混合物加至医用凡士林中,继续按照1500rpm的搅拌速度,搅拌5h,然后采用无菌净化及紫外线消毒,消毒温度为85℃,消毒时间为0.5h,灌装,密封。
实施例3
一种用于疏通乳腺的中药膏,按重量份计,包括中药A组分和B组分:
所述A组分包括野菊花30份、蒲公英45份、地丁草25份、炒王不留行15份、通草8.5份、丝瓜络18.5份、桔梗20份、川芎20.5份、当归20份、赤芍18.5份、益母草20份、炙甘草14.5份、乳香4.5份;
所述B组分包括鸡骨草20份、泽兰22份、芒硝4.5份、延胡索4.5份、马钱子1份、水红花子1.8份、鸡血藤11.5份、徐长卿3.5份、红景天8份、补骨脂2.5份、续断12份。
上述用于疏通乳腺的中药膏的制备方法,包括以下步骤:
步骤一、准确称量需要的各中药组分,分别洗净后晾干备用;
步骤二、将A组分中的野菊花、蒲公英、地丁草、炒王不留行、通草、丝瓜络、桔梗、川芎、当归、赤芍、益母草、炙甘草、乳香筛检,消毒灭菌后将各组分打成100目细粉,过筛去除其中纤维,留粉末备用;
步骤三、将B组分中的鸡骨草、泽兰、芒硝、延胡索、马钱子、水红花子、鸡血藤、徐长卿、红景天、补骨脂、续断,混合磨粉,然后加入4倍量的去离子水,混合煎煮70min,然后过滤取煎煮液,继续文火加热搅拌,熬制浸膏备用;
步骤四、将步骤二中得到的粉末与步骤三得到的浸膏,于1300rpm的搅拌速度下,搅拌4h,得到中药混合物,然后以医用凡士林为基质,按照中药混合物与医用凡士林的重量比为1:3,将中药混合物加至医用凡士林中,继续按照1250rpm的搅拌速度,搅拌3.5h,然后采用无菌净化及紫外线消毒,消毒温度为75℃,消毒时间为0.3h,灌装,密封。
实施例4
一种用于疏通乳腺的中药膏,按重量份计,包括中药A组分和B组分:
所述A组分包括野菊花25份、蒲公英30份、地丁草20份、炒王不留行10份、通草5份、丝瓜络15份、桔梗15份、川芎15份、当归15份、赤芍15份、益母草15份、炙甘草10份、乳香4份;
所述B组分包括鸡骨草15份、泽兰20份、芒硝3.5份、延胡索3份、马钱子1份、水红花子1份、鸡血藤10份、徐长卿2.5份、红景天8份、补骨脂1.5份、续断11份。
上述用于疏通乳腺的中药膏的制备步骤,与实施例3中的步骤一致。
实施例5
一种用于疏通乳腺的中药膏,按重量份计,包括中药A组分和B组分:
所述A组分包括野菊花35份、蒲公英50份、地丁草35份、炒王不留行15份、通草10份、丝瓜络25份、桔梗25份、川芎25份、当归25份、赤芍25份、益母草30份、炙甘草15份、乳香5份;
所述B组分包括鸡骨草25份、泽兰25份、芒硝5份、延胡索4.5份、马钱子2份、水红花子3份、鸡血藤13份、徐长卿5份、红景天9份、补骨脂3份、续断14份。
上述用于疏通乳腺的中药膏的制备步骤,与实施例3中的步骤一致。
临床研究
将患者分为治疗组和对照组,治疗组采用本发明实施例3中制得中药膏,对照组采用市售涂抹合成药膏,均为早晚各涂抹一次,治疗组与对照组都采用100例,按照年龄段,每个组又分为两个年龄段,青年组(25-30)60例,中年组(31-35岁)40例。两组病例的病程、症状轻重程度等,综合平均后无显著性差异,各组之间有可比性。两组病例均于用药后第3天、第5天、第7天、第14天观察主要症状和体征。
使用方法:外敷,取本品敷于患处表面,涂覆均匀,半小时后洗净即可。
症状的判断依据:
治愈:全身症状消失,肿块消散,身体恢复正常,经检查身体指标恢复正常。
显效:全身症状基本消失,局部疼痛减轻,经检查身体指标基本恢复正常。
有效:全身症状基本消失,局部疼痛有所减轻,经检查身体指标部分好转。
无效:症状无改善或加重,形成乳腺脓肿。
发明制得中药膏与市售合成药膏的疗效一览表,如表1。
表1本发明制得中药膏与市售合成药膏的疗效对比
分析表1可知,本发明治疗组的总有效率为96%,对照组的总有效率为89%,治疗组的有效率比对照组有明显提高;并且,治疗组的治愈率为73%,对照组的治愈率为60%。
针对治疗组的治愈患者,后期进行回访,均无复发,且无后遗症状、副作用。
典型病例1,齐某某,女,26岁,双侧乳房胀痛半年,近半月较前加重。查舌质暗,苔黄腻,脉弦,双乳弥漫性肿块,触痛。乳腺钼靶检查双侧乳腺增生。用该中药膏涂抹10天后,双乳胀痛减轻,继用中药膏涂抹30天后,双乳疼痛、双乳肿块均消失,舌质淡红,苔薄白,脉弦,乳腺钼靶检查双乳未见异常。
病例2,杨某,女,31岁,双侧乳房胀痛2个月,月经前加重。舌质紫暗有瘀斑,苔薄黄,脉沉,双乳触痛明显。用该中药膏涂抹7天后,双乳胀痛减轻,继用中药膏涂抹14天后,双乳疼痛消失。随访半年未复发。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换或改进等,均应包含在本发明的保护范围之内。
Claims (5)
1.一种用于疏通乳腺的中药膏,其特征在于,按重量份计,包括中药A组分和B组分:
所述A组分包括野菊花20-40份、蒲公英30-60份、地丁草20-40份、炒王不留行5-15份、通草5-12份、丝瓜络15-30份、桔梗10-30份、川芎10-30份、当归10-30份、赤芍10-30份、益母草15-40份、炙甘草5-15份、乳香3-5份;
所述B组分包括鸡骨草10-30份、泽兰20-30份、芒硝3-5份、延胡索3-5份、马钱子0.5-2份、水红花子1-5份、鸡血藤10-15份、徐长卿1-5份、红景天8-10份、补骨脂0.5-3份、续断10-15份。
2.根据权利要求1所述的一种用于疏通乳腺的中药膏,其特征在于,按重量份计,包括中药A组分和B组分:
所述A组分包括野菊花25-35份、蒲公英30-50份、地丁草20-35份、炒王不留行10-15份、通草5-10份、丝瓜络15-25份、桔梗15-25份、川芎15-25份、当归15-25份、赤芍15-25份、益母草15-30份、炙甘草10-15份、乳香4-5份;
所述B组分包括鸡骨草15-25份、泽兰20-25份、芒硝3.5-5份、延胡索3-4.5份、马钱子1-2份、水红花子1-3份、鸡血藤10-13份、徐长卿2.5-5份、红景天8-9份、补骨脂1.5-3份、续断11-14份。
3.根据权利要求1所述的一种用于疏通乳腺的中药膏,其特征在于,按重量份计,包括中药A组分和B组分:
所述A组分包括野菊花30份、蒲公英45份、地丁草25份、炒王不留行15份、通草8.5份、丝瓜络18.5份、桔梗20份、川芎20.5份、当归20份、赤芍18.5份、益母草20份、炙甘草14.5份、乳香4.5份;
所述B组分包括鸡骨草20份、泽兰22份、芒硝4.5份、延胡索4.5份、马钱子1份、水红花子1.8份、鸡血藤11.5份、徐长卿3.5份、红景天8份、补骨脂2.5份、续断12份。
4.一种权利要求1所述用于疏通乳腺的中药膏的制备方法,其特征在于,包括以下步骤:
步骤一、准确称量需要的各中药组分,分别洗净后晾干备用;
步骤二、将A组分中的野菊花、蒲公英、地丁草、炒王不留行、通草、丝瓜络、桔梗、川芎、当归、赤芍、益母草、炙甘草、乳香筛检,消毒灭菌后将各组分打成100目细粉,过筛去除其中纤维,留粉末备用;
步骤三、将B组分中的鸡骨草、泽兰、芒硝、延胡索、马钱子、水红花子、鸡血藤、徐长卿、红景天、补骨脂、续断,混合磨粉,然后加入3-5倍量的去离子水,混合煎煮60-80min,然后过滤取煎煮液,继续文火加热搅拌,熬制浸膏备用;
步骤四、将步骤二中得到的粉末与步骤三得到的浸膏,于1200-1500rpm的搅拌速度下,搅拌2-5h,得到中药混合物,然后以医用凡士林为基质,按照中药混合物与医用凡士林的重量比为1:3,将中药混合物加至医用凡士林中,继续按照1200-1500rpm的搅拌速度,搅拌2-5h,再次杀菌处理,灌装,密封。
5.根据权利要求4所述的用于疏通乳腺的中药膏的制备方法,其特征在于,所述的杀菌采用无菌净化及紫外线消毒,消毒温度为65-85℃,消毒时间为0.2-0.5h。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810701005.5A CN108686049A (zh) | 2018-06-29 | 2018-06-29 | 一种用于疏通乳腺的中药膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810701005.5A CN108686049A (zh) | 2018-06-29 | 2018-06-29 | 一种用于疏通乳腺的中药膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108686049A true CN108686049A (zh) | 2018-10-23 |
Family
ID=63851142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810701005.5A Pending CN108686049A (zh) | 2018-06-29 | 2018-06-29 | 一种用于疏通乳腺的中药膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108686049A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110327254A (zh) * | 2019-08-06 | 2019-10-15 | 湖南逸红颜生物科技有限公司 | 美胸精华油组 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1276225A (zh) * | 2000-05-17 | 2000-12-13 | 涂宏海 | 产后康及制备工艺 |
CN106620121A (zh) * | 2016-12-05 | 2017-05-10 | 通渭县中医医院 | 一种治疗肝郁气滞型乳腺增生的中药组合物 |
-
2018
- 2018-06-29 CN CN201810701005.5A patent/CN108686049A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1276225A (zh) * | 2000-05-17 | 2000-12-13 | 涂宏海 | 产后康及制备工艺 |
CN106620121A (zh) * | 2016-12-05 | 2017-05-10 | 通渭县中医医院 | 一种治疗肝郁气滞型乳腺增生的中药组合物 |
Non-Patent Citations (1)
Title |
---|
赵慧等: "复方柴胡合剂治疗乳腺增生", 《中国乡村医药》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110327254A (zh) * | 2019-08-06 | 2019-10-15 | 湖南逸红颜生物科技有限公司 | 美胸精华油组 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102488814B (zh) | 治疗奶牛乳房炎的中药组合物 | |
CN114010709A (zh) | 一种治疗近视外用中药膏及其制备方法 | |
CN102293931B (zh) | 一种中药组合物、临床制剂及制备方法 | |
CN109549958B (zh) | 治疗激素依赖性皮炎的组合物及其制备方法 | |
CN108686049A (zh) | 一种用于疏通乳腺的中药膏及其制备方法 | |
CN104324310A (zh) | 一种用于治疗免疫抑制后真菌性角膜炎的中药组合物及其制备方法 | |
CN108785600A (zh) | 一种用于调理乳腺增生的中药膏及其制备方法 | |
CN104547351A (zh) | 治疗鸡传染性鼻炎的中草药口服液 | |
CN103989771A (zh) | 珍珠粉烫伤膏 | |
CN103417914A (zh) | 用于治疗急性肾功能衰竭的中药组合物 | |
CN103599253B (zh) | 一种用于治疗老年人冬痒症的中药组合物 | |
CN111700989B (zh) | 一种祛风除湿、治疗足癣的中药组合物及制备方法 | |
CN102028856B (zh) | 治疗烧伤、烫伤的中草药药剂及其制备方法 | |
CN105641226A (zh) | 一种治疗痛经的热敷盐及制备方法 | |
CN107551030B (zh) | 一种抗静脉血栓形成的中药组合物、制剂及制备方法 | |
CN108186785A (zh) | 一种治疗慢性盆腔炎的十二味中药组合物及其应用 | |
CN104940629A (zh) | 一种治疗慢性骨髓炎的外用膏剂及制法 | |
CN104998079A (zh) | 一种治疗类风湿性关节炎的中药组合物 | |
CN105079198A (zh) | 一种用于治疗乳腺增生的中药组合物、口服剂及其制备方法 | |
CN105327176A (zh) | 一种防治硅肺的中药组合物及制备方法 | |
CN104435529A (zh) | 治疗跌打损伤的外敷制剂及制备方法 | |
CN112190679A (zh) | 一种治疗宫寒型盆腔炎外敷剂及其制备方法 | |
CN104758702A (zh) | 治疗胆结石的疏肝利胆药剂及制备方法 | |
CN104306734A (zh) | 治疗糖尿病坏疽外用膏药制剂及其制备方法 | |
CN103920009B (zh) | 一种用于治疗手术腹腔粘连的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181023 |